Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptic malignant syndrome.

H D Goldwasser1, J F Hooper

  • 1College of Community Health Sciences, University of Alabama, Tuscaloosa.

American Family Physician
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

House calls and alprazolam for agoraphobia.

American family physician·1991
Same author

New and future treatment of depression.

Alabama medicine : journal of the Medical Association of the State of Alabama·1989
Same author

Prediction of neuroleptic-induced dystonia.

Journal of clinical psychopharmacology·1989
Same author

Neuroleptic malignant syndrome: recognizing an unrecognized killer.

Journal of psychosocial nursing and mental health services·1989
Same author

Utility of the psychiatric screen among the Navajo of Chinle: a fourth-year clerkship experience.

American Indian and Alaska native mental health research : journal of the National Center·1989
Same author

Concomitant treatment of neuroleptic malignant syndrome and psychosis.

The British journal of psychiatry : the journal of mental science·1989

Neuroleptic malignant syndrome (NMS) is a rare but dangerous reaction to certain medications. Early diagnosis by family physicians is crucial for prompt treatment and patient safety.

Area of Science:

  • Pharmacology
  • Neurology
  • Internal Medicine

Background:

  • Neuroleptic malignant syndrome (NMS) is a rare, life-threatening adverse drug reaction.
  • It is primarily associated with neuroleptic medications but can affect patients with Parkinson's disease.
  • Prompt recognition and management are essential due to its potential lethality.

Observation:

  • Classic NMS symptoms include autonomic instability, muscle rigidity, hyperthermia, and altered mental status.
  • Neurologic symptoms beyond rigidity can also be present.
  • Family physicians often serve as the initial point of contact for these patients.

Findings:

  • NMS presents a complex clinical picture requiring rapid diagnostic assessment.
  • The syndrome's severity necessitates immediate medical intervention.

Related Experiment Videos

  • Timely diagnosis by frontline healthcare providers can prevent severe outcomes.

    • Implications:

    • Early identification of NMS by family physicians is critical for timely treatment.
    • Understanding NMS risk factors and presentation aids in differential diagnosis.
    • Effective management strategies are vital to mitigate NMS morbidity and mortality.